• Skip to main content
BC

biochimica clinica

en_US English
en_US English it_IT Italian
  • Home
  • Casi clinici
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • Archivio BC fino a 2024
  • Sottometti un articolo
  • Norme Autori
  • Cerca

RASSEGNE - Reviews

Volume:

Biochimica Clinica 2018; 42(3) 210-216

Pubblicato on-line:

July 18, 2018

DOI:

10.19186/BC_2018.041

Scarica in PDF:
Autenticazione richiesta

Shaping the epigenetic basis of Werner Syndrome

AUTORI

Tiziana Guastafierro1,2, Maria Giulia Bacalini3, Domenico Raimondo4, Antonella Marcoccia2,5, Claudio Franceschi6,7, Alberto Spanò1, Francesco Bondanini8
1Clinical Biochemistry Laboratory, Sandro Pertini Hospital, Rome, Italy
2Interdisciplinary, Interdepartmental and Specialistic Reference Center for Early Diagnosis of Scleroderma, Treatment of Sclerodermic Ulcers and Videocapillaroscopy (CRIIS), Sandro
3IRCCS Institute of Neurological Sciences, Bologna, Italy
4Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy
5Unit of Ischemic Microangiopathy and Sclerodermic Ulcers, Sandro Pertini Hospital, Rome, Italy
6Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy
7Interdepartmental Center “L. Galvani”, University of Bologna, Bologna, Italy
8Clinical Pathology Laboratory, Saint’ Eugenio Hospital, Rome, Italy

ABSTRACT

Werner syndrome is an autosomal recessive genetic disease responsible for a progeroid disorder including a plethora of premature clinical signs traditionally associated with physiological ageing. The molecular alterations that lead to all phenotypes associated the disease remain still unidentified. Here we describe our recent findings and results from literature about the possibility that epigenetic changes could be associated with Werner syndrome phenotype. Recent literature evidences that epigenetic mechanisms are at the basis of both physiological and pathological processes, like insulin production and secretion. Analysis of genome-wide DNA methylation profile in the whole blood from patients affected by Werner syndrome demonstrated enrichment of hypermethylated probes in glycosphingolipid biosynthesis, FoxO signalling and insulin signalling pathways, while hypomethylated probes were enriched in PI3KAkt signalling and focal adhesion pathways. Twenty-two differentially methylated genes belonging to the enriched pathways resulted differentially expressed in Werner syndrome fibroblasts. DNA methylation profiles analysis in Werner syndrome patients revealed differentially methylated regions in genes involved in other ageing phenotypes or associated syndromes like systemic sclerosis, dyskeratosis congenita and Down syndrome. Genome-wide epigenetics changes observed in the peripheral blood from patients with Werner syndrome provide new insight in the pathogenesis of the disease, highlighting in some cases a functional correlation of gene expression and methylation status

BIBLIOGRAFIA

HOME
PRIVACY POLICY
5x1000 Docemus

LOGO SIBioC

EDITORE RESPONSABILE
Alberto Oliaro

EDITORIAL SECRETARY
Edizioni Minerva Medica S.p.A.
Corso Bramante 83-85, 10126 Torino
T +39 011 678282
journals.dept@minervamedica.it

Designed by Biomedia srl
© 2025 SIBioC
P. IVA IT 06484860967